Anguilla

St. Vincent & Grenadines

Haiti

Grenada

Dominica

The Cayman Islands

Bermuda

Belize

The Bahamas

Barbados

Jamaica

Antigua & Barbuda

Trinidad & Tobago

St. Lucia

St. Kitts & Nevis

Suriname

Guyana

The Netherland Antilles

The British Virgin Islands

THE CARIBBEAN ASSOCIATION OF

MEDICAL TECHNOLOGISTS

Newsletter: Volume 1, Issue 3

For Laboratory Professionals

CONTRIBUTORS FOR SEPTEMBER:

Chris Seay (USA)

Shannon Newman (USA)

The Pan American Health Organization (PAHO)

ARTEL (USA)

Sheldon Simson (Suriname)

Earther Went (Barbados)

Delphia Theophane (St. Lucia)

Distributed: September2012

Distributed: September 2012

Word from the Liaison pg 2.

AMT Councillor Comments pg 3.

Progress toward Implementation of Human Papillomavirus Vaccination – The Americas pg 4.

10 Tips to Improve your Pipetting Technique pg 7.

Suriname pg 8.

Review Lab. Mathematics pg 10.

A Joke for the Road pg 11.

Medical Definitions pg 12.

Hi members welcome to the latest edition of the newsletter, we hope that you

will continue to enjoy the articles submitted by your colleagues from around the region. Please see the back page for the contact information of the education committee members.

CASMET RCM

Belize City, here we come!!

The next RCM will be in Belize from October 19 to 22, 2012.

Belize City Pier (Wikipedia.org)

2

2 TYPE TITLE HERE

After many years of loyal and dedicated service,

Dr. Gerard Boe has resigned as the CASMET

Liaison. Dr. Boe formed part of the original alliance

between AMT and CASMET and worked side by

side with James Mackey and others to maintain a

strong and positive relationship between AMT and

CASMET. Now the task of maintaining this

relationship has fallen on my shoulders and it is an

awesome task.

My first encounter with CASMET was in Tucson,

Arizona, which seems like so many years ago. At

that meeting, I heard a man speaking loudly, and

although he was in a wheelchair this proved not to be

a handicap for him, as he was ‘all over the place’.

His name was Norman Burke and he showed me

what a family CASMET was and I must admit still

is, even today.

AMT and CASMET have become a strong family

and my prayer, for the coming years, is that AMT

and CASMET grow from strength to strength to

maintain that sense of family in their organizations.

This strength will ensure the maintenance of stability

and continuity in the medical community of the

Caribbean region, however in order to do so

CASMET must be a leader in the medical field and

must give strength to their members.

Due to the changing landscape within the medical

fields, especially the laboratory, it has become

incumbent on CASMET to ensure the integrity and

competency of the medical laboratory personnel.

Therefore I want us to work together to form an

AMT and CASMET partnership, that will allow us

to work in harmony and fellowship. To this end I

must say that I am looking forward to attending the

meetings of the RCM and BGM, especially the BGM

in 2013, as this should prove to be a powerful and

productive meeting and I am hoping to meet as many

members of CASMET as possible.

However, before I say my farewells, I would like

to dispense with a little personal information. I was

originally trained in the laboratory in the United

States Air Force. My medical training started in

1973, and I worked in the military hospital as part of

the mobile hospital team, as well as in the civilian

hospitals not only in the United States, but also in

countries outside of the United States. After 20 years

of military duty, I completed my college studies at

Southwest Texas State University (now Texas State

University). Recently retired, my last stint in the

laboratory was at the St. Jude Children’s Research

Hospital.

I am married to a wonderful lady, and we have two

children and two grandchildren.

Safe travels and blessings to all,

Chris

Word from the Liaison: Chis Seay (AMT)

A QUOTE OF NOTE:

“I always remember the axiom: a leader...is like a shepherd. He

stays behind the flock, letting the most nimble go out ahead,

whereupon the others follow, not realizing that all along they are

being directed from behind.”

Nelson Mandela

3

3

Ray Dean, MT from North Carolina, Cynthia Jones, MT from

Georgia, Naomi Melvin, MT from Florida, and Georgia

Morrison, MT from South Carolina for receiving the Pillar

Award, J.D. Lookdoo, MT from Florida received the

Distinguished Achievement Award, and Harry Narine, MT,

RPT from Trinidad received the Exceptional Merit Award.

Writing award winners were: Gerald P. Boe, PhD, from South

Carolina-1st place technical award and Alice Macomber,

RN,RMA, AHI, RPT from Florida- 1st place in the feature

writing award and Maria Cristina Guzman, MT from Georgia-

2nd

place in the feature writing award. Publication awards: 1st

Place Journal Tennessee- Tenn-O-Scope, Kaye Tschop, editor

and 3rd place Newsletter-Georgia- Peaches and Peanuts- Chevy

Newham, editor.

Most Improved Publication- North Carolina-Tarheel Tech-

Tommie Williams, editor and a special thanks to the honor roll

states and to the 1st time attendees to the National convention

and I hope to see the 1st timers attend next year for their second

convention.

What is happening, and what will happen next.

Let’s not forget the week to recognize and celebrate the

medical assistants. This year the National Medical Assistants

Week is October 15th-19

th.

Mary Burden, MT was re-elected to the National Board and

Heather Herring was elected for the RMA position to the

National Board. Our new officers for is Mary Burden, MT as

President, Everett Bloodworth, MT as Vice-President, Jeff

Lavender as Secretary, and Janet Sesser as Treasurer. Linda

Jones was re-elected to AMTIE and new member elected was

Taffy Durfee. The new officers of AMTIE are Linda Jones,

MT as President, Art Contino, AHI,RMA as Vice-President,

Marty Hinkel, MT as Secretary and David Yocum as

Treasurer.

Make plans now to attend your state and national meeting. It’s

a great way to attend a family reunion and still get continuing

education at the same time. I wish each of my states a great

year.

Respectfully submitted,

Shannon H. Newman, BSMT AMT Southern District

Councillor

First, I would like to thank the Texas State Society for hosting

National Convention this year in San Antonio. Second, it is

always sad to see the end of the week at National Convention and

say good-bye to friends and family and third, if you were unable

to attend this year’s convention- you missed an awesome

meeting. There were some changes to the convention this year by

adding an evening session and one session during lunch.

“Breakfast of Champions” is now the “Lunch of Champions”

served on Tuesday at lunch. This year’s convention offered 24

hours of continuing education with wonderful speakers.

Next, I would like to give an update on membership and

education. Since March 2012, the education department has been

very active. The registered medical assistant on-line practice

exam went live as of June 7th. The cost is $30.00 for nonmember

and $25.00 for student members. The practice exam consists of

220 questions and it can be taken twice. The Education

Department has regrouped the step articles similar to the old CE

modules, which will be retired by the end of 2012. These new

packages went live on June 9th. There were 7 on-demand courses

from last annual meeting that went live in May. The cost for on-

demand courses and webinars are $15-$30 depending on the

amount of credits that are offered. Also, there will be a

membership survey sent out sometime in September and by

January 1, 2013; there will be on universal application. Also, you

can check facebook and youtube for information on this year’s

convention and other social events.

Next year’s annual meeting will be July 8-12, 2013 in

Pittsburgh, Pennsylvania at the Omni William Penn Hotel. The

cost is $119.00 plus 14% taxes (rate valid from July 2-15, 2013).

The 2014 meeting will be held in the Great Lakes District.

Next, I would like to congratulate the following members in the

South for their time and dedication to AMT: Paul Brown, MT

from Alabama received the Order of the Golden Microscope,

Chris Seay, MT from Tennessee received the O.C. “Skip”

Skinner Armed Services Award. Kay Fergason, MT from Florida

received the Cuviello Commitment to Excellence Award, Patricia

Poitier-Sands, RMA from Florida received the Silver Service

Award.

AMT Councillor Comments- Fall 2012

4

4 TYPE TITLE HERE

IMMUNIZE AND PROTECT YOUR FAMILYIMMUNIZE AND PROTECT YOUR FAMILY

Immunization Newsletter: Pan American Health Organization, October 2011 Progress Toward Implementation of Human Papillomavirus Vaccination – the Americas, 2006 – 2010: Volume XXXIII Number 5

Cervical cancer is a major cause of morbidity and mortality in the Americas, where an estimated 80,574 new cases and

36,058 deaths were reported in 2008, with 85% of this burden occurring in Latin America and the Caribbean [1]. Two oncogenic

Human Papillomavirus (HPV) types (16 and 18) cause approximately 70% of cervical cancers and a substantial proportion of other

HPV-related cancers [2]. HPV vaccination provides an opportunity to greatly reduce cervical cancer burden through primary

prevention of HPV infection. This report summarizes the progress toward HPV vaccine introduction in the Americas, focusing on

countries that have introduced the vaccine in national or regional immunization programs. As of January 2011, four countries in the

Americas had introduced HPV vaccine. Overcoming issues related to financing and delivery of HPV vaccine remains a key public

health challenge to more widespread implementation of HPV vaccination in the Americas.

Two brands of HPV vaccine are available. Both are effective against oncogenic types HPV 16 and 18: a quadrivalent

vaccine (Gardasil®, Merck & Co., Inc.) and a bivalent vaccine (Cervarix®, GlaxoSmithKline). Quadrivalent HPV vaccine is also

effective against nononcogenic types HPV 6 and 11, which cause most genital warts. Pre- and post-licensure studies have shown

that both vaccines are safe and well tolerated [3,4]. Because HPV infections are acquired soon after initiation of sexual activity,

HPV vaccine is most effective if administered before onset of sexual activity. The World Health Organization (WHO) recommends

a 3-dose vaccine schedule, completed over the course of 6 months, for a likely primary target population of girls within the age

range of 9 or 10 years through 13 years [3].

In April 2009, WHO issued a position statement recommending that routine HPV vaccination of females be included in

national immunization programs, provided that 1) cervical cancer and/or HPV-related diseases constitute a public health priority; 2)

vaccine introduction is programmatically feasible; 3) sustainable financing can be secured; and 4) cost-effectiveness of vaccination

strategies in the country or region is considered. Preferably, HPV vaccines should be introduced as part of a coordinated strategy to

prevent cervical cancer and should not undermine or divert funding from effective cervical cancer screening programs [3].

Information on HPV vaccine introduction in the United States and Canada was reviewed. Information about Latin America and the

Caribbean was obtained through the Pan American Health Organization.

TABLE: Implementation of human papillomavirus (HPV) vaccination in national immunization

programs, by country and selected characteristics — the Americas, 2006–2010

Country Year of

Implementation

Target Group & Age

Population

Catch – up Group Geographic Scope

United States* United States* United States* United States* United States*

Canada† Canada† Canada† Canada† Canada†

Panama Panama Panama Panama Panama

Mexico§ Mexico§ Mexico§ Mexico§ Mexico§

* In the United States, quadrivalent HPV vaccine is approved by the Food and Drug Administration for use in females and males; the

Advisory Committee on Immunization Practices (ACIP) states that quadrivalent HPV vaccine may be given to males aged 9–26 years, but

currently it is not part of the routine immunization

schedule for males.

† In Canada, quadrivalent HPV vaccine is approved for use in both females and males aged 9–26 years and females up to age 45 years by

Health Canada; no recommendations from the National Advisory Committee on Immunization currently exist for women aged >26 years or

for males of any age. Target ages vary across provinces and territories; the upper catch-up age in some jurisdictions ranges from 15 to 26

years.

§ In Mexico, target age and catch-up age ranges varied by year, with an upper catch-up age as high as 16 year

5

5

(PAHO), which, as part of ongoing cooperation with its member

states, monitors HPV vaccine introduction in the region.*

Country-specific information was verified by representatives of

PAHO member states. As of January 2011, four countries in the

Americas had included HPV vaccine in their immunization

programs: the United States, Canada, Panama, and Mexico

(Table). HPV vaccination coverage varied widely. For the 3-dose

vaccination series, coverage among girls aged 13–17 years in the

United States was 32% in 2010; in parts of Canada, 80%

coverage has been reported among girls in the target age ranges.

In the United States, HPV vaccine has been available since

2006. HPV vaccine administration occurs mainly through

pediatric and family medicine primary-care providers; a publicly

funded program, Vaccines for Children, provides vaccine at no

charge to children aged ≤18 years who are uninsured or meet

eligibility criteria. Coverage rates have increased each year since

introduction in 2006. In 2010, overall coverage among girls aged

13–17 years was 48.7% for ≥1 dose of HPV vaccine and 32.0%

for 3 doses [5].

In Canada, HPV vaccine has been available since 2006. School-

based HPV vaccination programs delivered by public health

agencies began in 2007, and all provinces and territories had

publicly funded programs in place by 2009 [6]. Year of

introduction, target age groups, and dosing schedules varied

across provinces and territories; however, all offered HPV

vaccine, free of charge, to girls in at least one of grades 4 to 9

(ages 9–15 years) [6]. Ten of the 13 jurisdictions offered the

vaccine to more than one grade as part of a time-limited catch-up

program [7]. Although most provinces and territories followed a

0-, 2-, 6-month dosing schedule, Quebec implemented a different

approach; the first 2 vaccine doses were administered in grade 4

(ages 9–10 years), and the third dose in grade 9 (ages 14–15

years) [7].

In September 2010, British Columbia also began using an

extended dosing schedule. Series coverage varied nationally

among jurisdictions that reported, with a range of 80% to 85% in

the Atlantic (eastern) provinces to 51% in Ontario, after the first

year of the program.

In Panama, the Ministry of Health added bivalent HPV vaccine

to the national immunization program in 2008 for a target

population of girls aged 10 years [8]. Vaccine has been

delivered through adolescent health services in both clinics and

schools. Coverage rates have improved since vaccine introduction

in 2008. In 2009, 1-dose coverage among girls aged 10 years was

89%, and 3-dose coverage was 46% [8]. In 2010, 3-dose coverage

was 67%.

In Mexico, HPV vaccine was introduced in 2008 to 125 targeted

municipalities (comprising approximately 5% of Mexico’s

population) with the lowest human development indexes, which

were estimated to have the highest incidence of cervical cancer

[8]. Quadrivalent HPV vaccine was delivered via mobile health

clinics to girls aged 12–16 years in these municipalities using a 0-

, 2-, 6-month dosing schedule [8]. In 2008, 1-dose coverage

among girls in the target age range within these municipalities

was 98%, and 3-dose coverage was 81%. In 2009, Mexico

expanded its HPV vaccination program to include 182

municipalities with the lowest human development index and

changed to an extended dosing schedule that targets girls aged 9–

12 years for the first 2 doses, delivered 6 months apart, followed

by the third dose 60 months later. Using the extended dosing

schedule, 1-dose coverage was 85%, and 2-dose coverage was

67%; 3-dose coverage at 60 months is yet to be measured. In

2011, Mexico’s National Immunization Council approved a

nationwide expansion of its HPV vaccination program to include

school-based vaccination of all girls aged 9 years.

What is already known on this topic?

Cervical cancer is a major cause of morbidity and mortality in the Americas, where an estimated 80,574 new cases and 36,058 deaths were

reported in 2008. Human papillomavirus (HPV) vaccines are safe and effective, and HPV vaccination offers an opportunity to reduce the

substantial burden of cervical cancer.

What is added by this report?

This report summarizes the progress toward HPV vaccine introduction in the Americas. As of January 2011, four (11%) of the 35 countries in the

Americas had included HPV vaccine in national or regional immunization programs: the United States, Canada, Panama, and Mexico. HPV

vaccination coverage varied widely. For the 3-dose vaccination series, coverage among girls aged 13–17 years in the United States was 32% in

2010; in parts of Canada, ≥80% coverage has been reported among girls in the target age ranges.

What are the implications for public health practice?

Overcoming issues related to financing and delivery of HPV vaccine remain key public health challenges to more widespread implementation

of HPV vaccination, especially in regions with a disproportionate burden of cervical cancers.

6

6 TYPE TITLE HERE

Editorial Note

HPV vaccines are safe and effective, and HPV vaccination

offers an opportunity to reduce the substantial burden of

cervical cancer for women in the Americas. Although

progress has been made in HPV vaccine introduction in the

Americas, only four of 35 (11%) PAHO countries

included the vaccine in their immunization programs as of

January 2011. Several important challenges to

implementation of HPV vaccination in the Americas exist,

including cost, competing demands for the introduction of

other new vaccines, and limited health-care delivery

systems that reach adolescents.

HPV vaccines are among the most expensive vaccines

available, and current prices in highincome countries† are

not affordable for lowand middle-income countries. As with

other new vaccines, international cooperation aims to

increase HPV vaccine affordability by reducing the cost per

dose. For instance, PAHO’s Revolving Fund for vaccine

procurement is a mechanism that aggregates vaccine

purchases by countries in Latin America and the Caribbean

and thus achieves economies of scale. Under this fund, HPV

vaccine was first offered in 2010; the price per dose for

participating countries in mid-2011 was $14 (U.S. dollars).

The GAVI Alliance (formerly the Global Alliance for

Vaccines and Immunization) is a public-private partnership

that provides financing and programmatic support for

vaccine introduction in low-income countries. As of

October 2011, GAVI had not committed funds for HPV

vaccination, and only three Latin American and Caribbean

countries (Guyana, Haiti, and Nicaragua) were GAVI-

eligible, limiting the potential impact of this program in the

Americas. Access to HPV vaccine at more affordable prices

is critical for widespread introduction and long-term

sustainability of this vaccine in Latin America and the

Caribbean, where most countries are considered middle-

income.

Another important challenge for implementation of HPV

vaccination is limited experience in health-care delivery to

adolescents. Historically, most immunization programs

have focused on infant vaccination and therefore are less

experienced with accessing and vaccinating adolescents.

Some countries in the region have participated in demonstration

projects to explore options for vaccine delivery. HPV

vaccination projects, including school-based implementation

projects, have been piloted in Bermuda, Bolivia, Cayman

Islands, Haiti, and Peru. In addition to Mexico, the

governments of Argentina, Guyana, Peru, and Suriname have

been planning to implement national HPV vaccination

programs in 2011. Efforts to identify the most effective and

affordable strategies for vaccine delivery continue to be

investigated [9]. Although some countries are using an

extended 3-dose schedule, PAHO/WHO and CDC recommend

a 3-dose schedule administered over 6 months.

The pace of global introduction of vaccines can be slow. For

example, worldwide introduction of hepatitis B vaccine took

approximately 20 years. During the past 4 years, several

countries in Latin America have introduced rotavirus and/ or

pneumococcal conjugate vaccines, marking the first time that

new vaccines were introduced in middle- and low-income

countries at the same time as in high-income countries [10].

Additional strategies are needed to overcome the challenges to

increasing HPV vaccine introduction, especially in regions with

a disproportionate burden of cervical cancers. New

opportunities to focus on health issues for women could

support prioritization of this vaccine for Latin America and the

Caribbean. ■

Reported by

Andrea S. Vicari, DVM, PhD, Dilsa G. Lara, Pan American Health

Organization. Shelley Deks, MD, Surveillance and Epidemiology, Ontario

Agency for Health Protection and Promotion, Ontario, Canada. Susana P.

Cerón Mireles, MD, irella Loustalot Laclette San Román, MD, Raquel

Espinosa Romero, MD, National Center for Gender Equity and Reproductive

Health; Maria del Carmen Domínguez Mulato, MD, Vesta Richardson López-

Collada, MD, National Center for Child and Adolescent Health, Ministry of

Health, Mexico. Yadira de Moltó, MD, Itzel S. de Hewitt, Ministry of Health,

Panama. Mona Saraiya, MD, Div of Cancer Prevention and Control, National

Center for Chronic Disease Prevention and Health Promotion; Terri Hyde,

MD, Global Immunization Div, National Center for Immunization and

Respiratory Diseases; Lauri E. Markowitz, MD, Eileen F. Dunne, MD, Elissa

Meites, MD, Diya Surie, Div of Sexually Transmitted Diseases, National

Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, CDC.

Corresponding contributor: Elissa Meites, emeites@cdc.gov, 404-639-8368.

7

7

8

8 TYPE TITLE HERE

Suriname: The People, The Culture, The Place

Who said Medical Technology is confined to a lab?

On April 29th 2012 during the Medical Professionals’ Week the Suriname branch of CASMET organized and

funded an Outdoor Educational Brunch. Yes! We took our discipline outside and forgot our lab coats in the lab.

The purpose was to do something different that would attract members and be both fun and educational. The

Brunch was well attended; lab professionals came all dressed up - some even in water boots in anticipation of the

outdoor tour.

The outdoor tour took place in a huge and exotic garden that has fruits from many countries such as

Jamaica’s Ackee, etc. The garden is owned by one of our own – a senior Medical Technologist who works at the

Academic Hospital in Suriname. He explained the origin of the plants and other educational facts about the plants

and fruits in his garden. After the tour there was a quiz to refresh the knowledge of the Medical Professionals. It

was really entertaining to see colleagues and other professionals running to grab a bottle to answer a question about

our discipline and simply having a good time with each other. Not only were the people competing in the quiz

refreshed but also the spectators. This was evident by the look of concentration and active facial expressions.

People were really bonding across departments and creating friendships outside of the work place.

There was plenty to eat for breakfast and lunch. At breakfast there were fresh fruits such as bananas and

apples. The yogurt and donuts disappeared quickly, along with the coffee, tea and fruit juice. Lunch was prepared

on site and the aroma of good Suriname cooking filled the air. At lunch everyone enjoyed the crispy fries with our

classic local nut sauce, BBQ chicken and homemade coleslaw. This activity was a remarkable success and the

professionals reported that they are anticipating the next one.

9

9

Suriname: The People, The Culture, The Place

10

10 TYPE TITLE HERE

A REVIEW IN LABORATORY MATHEMATICS

Let’s see if you can remember how it’s done:

1. A stock potassium solution has a concentration of 500 mg%. A 1/5 dilution of this

standard is made. What would be the concentration of the final solution?

2. You need 200ml of a 1:300 solution of Glucose /L. What dilution is necessary to

prepare a working standard containing 5mg / 100 ml.

3. Give the ratio of 3ml of serum diluted with 17ml of water. Give the dilution of the

solution.

4. A glucose standard contains 5 mg of glucose/ml. A 1/10 dilution of this standard would

contain how much glucose?

5. You have a stock standard with a stated concentration of 1000 mg/dl. How would you

prepare 50 ml of a 5.0 mg/dl working standard?

6. You need 50 ml of HCL solution which is 0.02N. You have on hand 0.5N solution. How

would you prepare this solution to give the desired volume and concentration?

7. If 1 ml of a 1:4 dilution is further diluted by adding to it 1.5 ml of distilled water,

the final dilution is:

a. 1:5

b. 1:6

c. 1:10

d. 1:25

8. A stock standard solution contains 200 g of glucose /l. What dilution is necessary to

prepare a working standard containing 5mg /100 ml.

a. 1/500 d. 1/100

b. 1/1000 e. 1/400

c. 1/4000

9. The following quantities are placed in a test tube: 0.1 sample, 2.9ml of diluent, 0.5 ml

of reagent #1, 0.5 ml of reagent #2. What is the final dilution of the sample?

11

11

A Joke For the Road!!

HOW TO CALL THE POLICE WHEN YOU'RE OLD,

AND DON'T MOVE FAST ANYMORE!

GEORGE PHILLIPS, an elderly man, from Walled Lake, Michigan, was going up to bed,

when his wife told him that he'd left the light on in the garden shed, which she could

see from the bedroom window. George opened the back door to go turn off the light,

but saw that there were people in the shed stealing things.

He phoned the police, who asked "Is someone in your house?"

He said "No, but some people are breaking into my garden shed and stealing from me.

Then the police dispatcher said "All patrols are busy. You should lock your doors and an

officer will be along when one is available"

George said, "Okay."

He hung up the phone and counted to 30. Then he phoned the police again.

"Hello, I just called you a few seconds ago because there were people stealing things from

my shed. Well, you don't have to worry about them now because I just shot and killed

them both." then he hung up.

Within five minutes, six Police Cars, a SWAT Team, a Helicopter, two Fire Trucks, a

Paramedic, and an Ambulance showed up at the Phillips' residence, and caught the

burglars red-handed.

One of the Policemen said to George, "I thought you said that you killed them!"

George said,”I thought you said there was nobody available!"

(True Story) I LOVE IT! Don't mess with old people.

Compliments of Delphia Theophane

12

12 TYPE TITLE HERE

Medical Definitions with a Difference!!!

Artery: The study of paintings.

Bacteria: Back door to cafeteria.

Barium: What doctors do when patients die.

Cesarean Section: A neighborhood in Rome.

Catscan: Searching for kitty.

Cauterize: Made eye contact with her.

Colic: A sheep dog.

Coma: A punctuation mark.

D & C: Where Washington is.

Dilate: To live long.

Enema: Not a friend.

Fester: Quicker than someone else.

Fibula: A small lie.

Genital: Non-Jewish person.

G. I. Series: World Series of military baseball.

Hangnail: What you hang your coat on.

Impotent: Distinguished, well known.

Labor Pain: Getting hurt at work.

Medical Staff: A Doctor's cane.

Morbid: A higher offer than I bid.

Nitrates: Cheaper than day.

Node: Was aware of.

Outpatient: A person who has fainted.

Pap Smear: A fatherhood test.

Pelvis: Second cousin to Elvis.

Post-Operative: A letter carrier.

Recovery Room: Place to do upholstery.

Rectum: Darn near killed him.

Secretion: Hiding something.

Seizure: Roman emperor.

Tablet: A small table.

Terminal Illness: Getting sick at the airport.

Tumor: More than one.

Urine: Opposite of you're out.

Varicose: Nearby, close by. Vein: Conceited

http://www.butlerwebs.com/jokes/medical2.htm

Adapted from http://www.butlerwebs.com/jokes/medical2.htm

13

13

Education Committee Contact Information:

Earther Went (Chairperson): ewent@bcc.edu.bb

Sashoy Duncan: sashoyforbes@hotmail.com

Marcia Robinson- Walters: brian_0299@hotmail.com

Delphia Theophane: djphia41@hotmail.com

Tamara Chambers: tamara.chambers@ncu.edu.jm

This Newsletter is a production of the

Education Committee of the Caribbean

Association of Medical Technologists

All rights reserved @ March 31St 2012